Pain and Pleasure

Executive summary

The strongest conclusion from contemporary neuroscience and psychology is not that pain and pleasure are simple opposites, and also not that “more pain, more pleasure” is generally true. The more defensible conclusion is narrower: brief, bounded, meaningful, and controllable pain can increase later pleasure mainly through contrast, relief, reward prediction, and context-dependent modulation. Outside those conditions—especially in chronic, unpredictable, uncontrollable, or traumatic pain—the relationship typically reverses, and more pain means less pleasure, less reward responsiveness, and more anhedonia. citeturn39search0turn25view0turn23search0turn14search0turn21search2turn22search0

Pain is now officially defined by the International Association for the Study of Pain as “an unpleasant sensory and emotional experience associated with, or resembling that associated with, actual or potential tissue damage,” with explicit notes that pain is personal and shaped by biological, psychological, and social factors. In affective neuroscience, “pleasure” is not a single chemical but a set of processes—especially hedonic liking, motivational wanting, and reward learning—implemented by partially overlapping but dissociable brain systems. citeturn37search0turn37search2turn38search1turn10search4

Neurally, the overlap is real. Pain and pleasure both recruit valuation and motivational systems involving the anterior cingulate cortex, insula, amygdala, ventromedial/orbitofrontal prefrontal cortex, nucleus accumbens, periaqueductal gray, and descending brainstem control networks. Endogenous opioids contribute to analgesia and hedonic liking; dopamine contributes more to incentive salience, reward prediction, and motivated pursuit than to pleasure itself; endocannabinoids appear especially important in some euphoric hypoalgesic states such as the runner’s high. citeturn39search0turn38search1turn7search0turn30search0turn32search0

Empirically, four findings are especially robust. First, pain relief is rewarding in both humans and animals, engaging mesolimbic circuitry. Second, the offset of acute pain can increase subsequent pleasure, including hedonic reactions and responsiveness to appetitive stimuli. Third, reward can inhibit pain, and pain can in turn alter reward processing. Fourth, chronic pain usually impairs reward function, including ventral striatal dopamine signaling, rather than amplifying pleasure. citeturn8search0turn29search0turn25view0turn28search0turn23search0turn9search0turn9search1turn22search0turn22search3

Masochism and consensual BDSM do not show that all pain becomes pleasurable. The literature instead points to high context dependence: selective descending pain inhibition, altered meaning, consent, anticipation, safety, and erotic framing can change the experience of pain in some people and situations. Baseline pain sensitivity findings are mixed, but context-specific modulation appears credible. This is very different from chronic pain, nonconsensual pain, or pain that causes distress and impairment. citeturn14search0turn40search3turn15search1turn36search0

The practical implication is clear: clinicians, therapists, and sexual-health practitioners should not romanticize suffering. If pain sometimes yields pleasure, it is usually because of relief, meaning, predictability, control, learning, and reward context—not because pain itself is intrinsically pleasurable in a linear dose-response way. citeturn24search0turn24search1turn20search0turn21search2turn15search1

Definitions and neural architecture

Pain is not the same thing as nociception. Nociception refers to neural processing of potentially tissue-damaging input, whereas pain is the consciously experienced, aversive, sensory-emotional state. The revised IASP definition and notes emphasize that pain is personal, learned, and biopsychosocial, and that pain cannot be inferred solely from peripheral firing. That point matters here because any claim that pain “becomes pleasure” must distinguish a sensory signal from the full conscious experience attached to it. citeturn37search0turn37search2

Pleasure is likewise not a single construct. Modern reward neuroscience separates liking from wanting and from learning. Mu-opioid signaling in specific “hedonic hotspots” of the nucleus accumbens shell and ventral pallidum is especially tied to liking, while mesolimbic dopamine is more tightly linked to wanting, incentive salience, and reward prediction errors. This is one reason the folk phrase “dopamine = pleasure” is misleading. citeturn38search1turn31search1turn31search4turn10search4

Pain and pleasure overlap because both depend on systems that compute salience, value, prediction, and homeostatic significance. A classic review by Leknes and Tracey argues for a “common neurobiology” centered on opioids, dopamine, and overlapping structures such as ACC, insula, amygdala, nucleus accumbens, and orbitofrontal/vmPFC regions. Pain and reward also mutually inhibit one another: reward can reduce pain, and pain can disrupt or reshape reward processing. citeturn39search0turn9search0turn9search1

Endogenous opioids are central to this overlap. Sustained pain in healthy humans triggers endogenous opioid release in cortical and subcortical regions, and placebo analgesia also recruits mu-opioid neurotransmission. This means the brain’s internal analgesic chemistry is not separate from reward chemistry; it is partly the same system. citeturn7search0turn7search2turn30search2

Dopamine enters most strongly at the level of motivation and expectation. During placebo administration, nucleus accumbens dopamine release tracks anticipated benefit and actual placebo analgesia, and individual reward responsiveness explains a meaningful share of placebo analgesia variance. By contrast, chronic back pain is associated with altered ventral striatal dopamine neurotransmission, consistent with the idea that ongoing pain often degrades, rather than augments, reward capacity. citeturn30search0turn22search0

Endocannabinoids matter too. In humans, opioid blockade does not abolish exercise-induced euphoria and anxiolysis, whereas running reliably raises endocannabinoid levels. So even in “hurts-so-good” exercise contexts, the pleasurable component is not reducible to endogenous opioids alone. citeturn32search0turn32search3

Neural circuits and neurotransmitters

System or node	Role in pain	Role in pleasure, reward, or relief	Why it matters for the pain–pleasure relationship	DOI
Insula and dorsal ACC	Salience, interoception, affective unpleasantness, action readiness	Valuation and salience integration for motivationally relevant outcomes	Shared coding of significance helps explain why reward and pain interact rather than remaining fully separate	10.1038/nrn2333
PAG–RVM descending system	Top-down analgesia and nociceptive control	Opioid-sensitive modulation of aversive states and defensive action	Control over pain changes how painful stimulation is experienced and whether offset becomes rewarding	10.1126/science.1060952
Nucleus accumbens	Relief valuation, pain-related motivational processing	Prediction error, incentive salience, relief reward	Relief pleasantness and placebo responses recruit NAc; chronic pain alters its dopamine function	10.1371/journal.pone.0017870; 10.1016/j.neuron.2007.06.028; 10.1523/JNEUROSCI.4605-14.2015
vmPFC and OFC	Reappraisal, safety valuation, pain modulation	Subjective value, reward pleasantness, integration of outcomes	Reward analgesia and relief-related valuation both involve vmPFC/OFC	10.1371/journal.pone.0017870; 10.1093/brain/aww431
Ventral tegmental area dopamine	Motivates escape/avoidance and adaptive action	Wanting, reinforcement, reward prediction	Pain relief activates dopaminergic reward circuitry, especially when ongoing pain is present	10.1073/pnas.1214605109
Ventral pallidum and accumbens hedonic hotspots	Limited direct role in nociception	Mu-opioid amplification of hedonic liking	Pleasure is not just dopamine; opioid hotspots are crucial for genuine liking	10.1177/1073858406293154; 10.1016/j.neuron.2015.02.018
Amygdala	Threat, aversive learning, pain affect	Value learning for both appetitive and aversive cues	Helps assign meaning and context to pain, including fear and relief expectations	10.1038/nrn2333; 10.1523/JNEUROSCI.1400-13.2013
Endogenous mu-opioid system	Analgesia during sustained pain and placebo	Hedonic liking, comfort, relief	One of the clearest biological bridges between pain reduction and pleasure	10.1126/science.1060952; 10.1523/JNEUROSCI.0439-05.2005; 10.1073/pnas.0702413104
Mesolimbic dopamine	Pain changes motivated behavior and reward sensitivity	Wanting, reward expectation, reinforcement learning	Explains why pain relief can become strongly sought even when pleasure itself is modest	10.1037/amp0000059; 10.1016/j.neuron.2007.06.028
Endocannabinoid system	Hypoalgesia and stress buffering	Euphoria, anxiolysis, flow-like exercise states	Important reminder that “endorphin release” is not the whole story in pain-linked pleasure states	10.1016/j.psyneuen.2021.105173; 10.1177/10738584211069981

The table above synthesizes established reviews and primary studies on shared pain–reward circuitry and neuromodulation. citeturn39search0turn38search1turn31search1turn25view0turn30search0turn30search2turn8search0turn22search0turn32search0

Neural circuit relationships

flowchart LR
    A[Noxious input] --> B[Spinal dorsal horn]
    B --> C[Thalamus]
    C --> D[Insula]
    C --> E[dACC]
    C --> F[Somatosensory cortex]
    D --> G[vmPFC/OFC]
    E --> G
    D --> H[Amygdala]
    E --> H

    I[Expectation meaning context] --> G
    I --> H
    I --> J[PAG-RVM descending control]

    J --> B
    K[Endogenous opioids] --> J
    K --> L[Nucleus accumbens]
    M[VTA dopamine] --> L
    L --> G
    N[Relief safety analgesia] --> L
    N --> G

    O[Chronic pain] -. dysregulates .-> L
    O -. dysregulates .-> K

This schematic is a simplification, but it captures the key consensus: nociceptive pathways and reward/valuation pathways are deeply interlocked, with expectation and descending control changing whether a painful event remains purely aversive or becomes part of a relief/reward sequence. citeturn39search0turn25view0turn8search0turn22search0

Theories and functional explanations

Opponent-process theory remains the cleanest psychological framework for “hurts so good.” Solomon and Corbit proposed that hedonic states evoke opposing processes that restore homeostasis; under repeated or intense stimulation, the secondary opponent state can become stronger or more noticeable. Applied to pain, that means an aversive “a-process” can be followed by a rewarding “b-process” of relief, calm, or even pleasure once the pain ends. citeturn10search0turn29search2turn28search0

Pain-offset relief is the most direct descendant of that idea in modern affective science. Acute pain offset can simultaneously increase positive affect and reduce negative affect, and the magnitude of relief rises with preceding pain intensity under laboratory conditions. The important nuance is that what scales is usually relief from pain, not a simple transformation of pain itself into pleasure. citeturn28search0turn29search2turn23search0

Incentive-sensitization theory adds a second layer. Because wanting and liking are dissociable, repeated pairing of cues with analgesia or relief could sensitize the motivational pull of those cues even when hedonic benefit does not grow proportionally. That framework is best established in addiction, but it is highly relevant to pain relief, opioid reinforcement, and possibly compulsive relief-seeking behaviors. This is partly an inference from the broader reward literature, not a universal theorem for all pain states. citeturn10search4turn21search2turn8search0

From an evolutionary perspective, pain’s basic protective value is uncontroversial: it promotes withdrawal, guarding, learning, and adaptive reprioritization. The reward value of relief also makes sense adaptively, because organisms that learn which actions, places, or cues predict the reduction of bodily threat should survive better. Animal literature on pain-relief learning—from fruit flies to rats—fits that logic well. citeturn37search0turn34search0turn34search3turn8search0

A more provocative evolutionary idea is that some persistent pain mechanisms may themselves be adaptive in certain contexts, by maintaining hypervigilance during long-lasting impairment. Walters and colleagues argue that persistent nociceptor hyperactivity may, in at least some species and conditions, have been selected because it protects vulnerable injured organisms from renewed attack. Even on that view, however, chronic pain is not thereby pleasurable; it is costly and only conditionally adaptive. citeturn17search0turn17search1

The social-signaling literature supports a different pathway from pain to value: costly ordeal. High-cost rituals can strengthen social bonding and credibly signal commitment, and more painful rituals are often reported as more bonding. That mechanism is better supported for group cohesion than for pleasure per se, and the evidence for direct mate-selection effects of pain endurance is more indirect, usually routed through broader theories of costly signaling and risk taking. citeturn16search1turn16search3turn16search5

That matters for the “mate selection” part of your question. There is some evolutionary plausibility that painful or risky displays can function as honest signals of quality, commitment, or fearlessness, but the direct empirical literature on “pain itself increases sexual attractiveness because it creates pleasure” is sparse. The stronger evidence concerns signaling, bonding, and risk cues—not literal hedonic conversion of pain into pleasure. citeturn16search3turn16search5turn16search0

Empirical evidence across experiments and clinics

The overall empirical picture is asymmetric. The literature strongly supports relief reward, contrast effects, and contextual revaluation. It gives much weaker support to the blanket claim that increasing pain directly increases pleasure in a monotonic way. citeturn25view0turn28search0turn23search0turn21search2

In humans, Seymour and colleagues showed that predictive learning of pain relief recruits neural processes similar to reward learning, especially in striatal and orbitofrontal systems. Leknes and colleagues later showed that relief and appetitive reward converge in vmPFC, but only relief pleasantness covaries with nucleus accumbens activation and with dread/pessimism. That is a crucial result: the pleasantness of relief depends on the negative expectation that preceded it. citeturn29search0turn25view0

Psychophysiological evidence points in the same direction. Franklin and colleagues found that pain offset both increased positive affect and reduced negative affect for several seconds. Bastian and colleagues showed that acute pain offset increased responsiveness to pleasant tastes, including chocolate enjoyment. These studies support a real “contrast” phenomenon: following brief pain, ordinary reward can feel better. citeturn28search0turn23search0

The interaction also runs the other way. Monetary wins reduce concurrent pain, with medial OFC activity tracking this reward-based analgesia. Conversely, experimentally induced pain changes neural responses to reward in mPFC and alters mPFC–NAc connectivity, showing that pain can reshape how rewards are processed even in healthy adults. citeturn9search0turn9search1

Analgesia itself is rewarding, especially when pain is ongoing. In a rat postsurgical pain model, local anesthetic relief produced conditioned place preference, activated ventral tegmental dopaminergic neurons, and increased nucleus accumbens dopamine release. This state dependence is important: analgesia is not equally rewarding in the absence of pain. citeturn8search0turn21search1

Human placebo studies make the same point with endogenous chemistry. Sustained pain recruits endogenous opioid release; placebo analgesia activates mu-opioid neurotransmission and nucleus accumbens dopamine; and individual differences in reward responding explain about 28% of the variance in placebo analgesia formation in one Neuron study. Placebo and nocebo effects also show opposite opioid and dopaminergic signatures. citeturn7search0turn30search2turn30search0turn30search1

The chronic-pain story is very different. In chronic back pain, ventral striatal dopamine neurotransmission is altered, and endogenous opioid functional measures are also abnormal. Reviews of reward and motivation in pain converge on the idea that chronic pain often co-occurs with anhedonia and reward dysregulation. So whatever “more pain, more pleasure” may describe for acute offset, it generally fails for persistent clinical pain. citeturn22search0turn22search3turn21search2

Consensual masochistic and BDSM contexts offer perhaps the most intuitive challenge to the usual opposition between pain and pleasure, but the evidence still favors context-specific modulation rather than global reversal. In men with masochistic behavior, masochistic images selectively reduced the RIII nociceptive reflex, suggesting descending inhibition specifically in a masochistic context. In a BDSM interaction study, practitioners showed higher overall pain thresholds, and submissives showed temporary elevations in threshold after interaction. A systematic review concluded that the biology literature is still small, but supports effects on cortisol, pain sensitivity, and psychophysiology more than direct proof of an “endorphin explanation.” citeturn14search0turn40search3turn15search1

This context dependence also appears in how clinicians distinguish consensual BDSM from disorder. Sexual masochism disorder requires distress, impairment, or harm, whereas most masochistic interests do not meet disorder criteria. That distinction is conceptually aligned with the experimental literature: consent, safety, expectation, and meaning are not side details—they are mechanistically central. citeturn36search0turn15search1

Finally, exercise shows a related but important nuance. Endurance exercise can produce hypoalgesia, anxiolysis, and euphoria, but in humans these effects do not appear to depend primarily on endogenous opioid receptor occupancy; endocannabinoids are stronger candidates. This undercuts simplistic “endorphin release explains all pleasurable pain” stories. citeturn32search0turn32search3

Selected study table

Study	Sample or model	Methods	Main finding for the pain–pleasure question	Effect size or extra detail	DOI
Zubieta et al. 2001	Healthy adults	PET during sustained pain	Pain itself triggered endogenous mu-opioid release in multiple brain regions, linked to reduced sensory and affective pain	Quantitative effect size not reported in abstract	10.1126/science.1060952
Seymour et al. 2005	Healthy adults	fMRI pain-relief learning	The brain learns pain relief in ways resembling appetitive reward learning	NR in abstract	10.1038/nn1527
Scott et al. 2007	Healthy adults; PET subset n=14	Placebo analgesia with PET and fMRI reward task	Placebo activated NAc dopamine, and reward responsiveness predicted placebo analgesia	Reward responsiveness explained about 28% of variance	10.1016/j.neuron.2007.06.028
Leknes et al. 2011	18 healthy volunteers	fMRI comparing relief and appetitive reward	vmPFC overlap for reward and relief, but NAc tracked relief pleasantness specifically as a function of dread/pessimism	Relief depends on negative expectation	10.1371/journal.pone.0017870
Franklin et al. 2013	Healthy adults	Psychophysiology during pain offset	Pain offset simultaneously increased positive affect and reduced negative affect	Quantitative effect sizes not reported in abstract	10.1177/0956797612458805
Bastian et al. 2014	Three adult experiments	Cold-pressor pain then taste testing	Acute pain offset increased enjoyment and sensitivity to gustatory reward	Quantitative effect sizes not reported in abstract	10.1016/j.appet.2013.10.011
Navratilova et al. 2012	Rat postsurgical pain model	Conditioned place preference, VTA and NAc measures	Relief of ongoing pain was rewarding and activated mesolimbic dopamine circuitry	State-dependent reward from analgesia	10.1073/pnas.1214605109
Martikainen et al. 2015	16 chronic back pain patients; 16 controls	PET with pain challenge	Chronic back pain associated with altered ventral striatal dopamine neurotransmission and linked opioid dysregulation	Suggests reward-system impairment, not hedonic enhancement	10.1523/JNEUROSCI.4605-14.2015
Baudic et al. 2022	15 men with masochistic behavior; 15 controls	RIII nociceptive reflex under neutral, erotic, negative, and masochistic image contexts	Masochistic context selectively engaged descending pain inhibition in masochistic participants	Context-specific effect	10.1002/ejp.2037
Wuyts et al. 2021	34 dominants, 33 submissives, 24 controls	Pain thresholds before and after BDSM interaction	BDSM practitioners showed higher thresholds overall; submissives showed temporary post-interaction threshold elevation	Supports temporary, context-bound modulation	10.1016/j.jsxm.2021.01.001

This study table summarizes the highest-confidence primary reports most relevant to the central question. citeturn7search0turn29search0turn30search0turn25view0turn28search0turn23search0turn8search0turn22search0turn14search0turn40search3

Boundary conditions and moderators

If pain increases pleasure, it usually does so when the pain is acute rather than chronic, followed by clear offset, and embedded in a context that makes the offset meaningful. Relief pleasantness scales with preceding pain intensity in laboratory settings, but that does not generalize to chronic or inescapable pain. citeturn29search2turn28search0turn22search0turn21search2

Predictability matters. Pain unpredictability can reverse how humans evaluate relief-associated cues: implicit and explicit valence can split, and predictable versus unpredictable pain changes the valence assigned to relief-related stimuli. Negative expectation is part of what makes relief pleasant in the first place. citeturn24search1turn29search3turn25view0

Control matters. Merely believing pain is controllable reduces activation in core pain-related regions such as ACC, insula, and S2. That is highly relevant to sexual and ritual contexts, where agency, safewords, consent, and negotiated roles can substantially alter the experience. citeturn24search0turn24search2turn14search0turn36search0

Meaning and interpersonal context matter as well. Benevolent intentions make shocks hurt less, massages feel more pleasurable, and candy taste sweeter. In consensual BDSM, “good pain” is not just nociceptive intensity; it is pain embedded in shared scripts of trust, power exchange, eroticism, and safety. citeturn23search2turn15search1turn14search0

Individual differences are major moderators. Pessimism and dread amplify relief-related NAc responses; reward responsiveness predicts placebo analgesia; fear of pain and catastrophizing moderate threshold changes in BDSM contexts; and some people deliberately use pain as an emotion-regulation strategy. There is no single universal dose-response curve from pain to pleasure. citeturn25view0turn30search0turn40search0turn35search4

Learning and expectation further shape outcomes. Pain-relief learning is demonstrable in fruit flies, humans can acquire implicit positive valence for relief-associated cues even when explicit reports stay negative, and placebo/nocebo effects recruit reward- and opioid-related systems. That makes “more pain, more pleasure” partly a learning problem: the same physical input can be revalued differently depending on prior associations. citeturn34search0turn34search3turn29search3turn20search0turn30search1

Cultural norms also influence how pain is perceived, expressed, tolerated, and clinically treated. Cultural expectations can determine whether pain is normalized, dramatized, stoically suppressed, ritualized, or medicalized. That does not mean culture overrides biology, but it does mean the same nociceptive input need not have the same affective meaning across social worlds. citeturn19search0turn19search3

When pain increases pleasure

flowchart TD
    A[Painful event] --> B{Is it brief and does it end clearly?}
    B -- No --> X[Usually less pleasure and more distress]
    B -- Yes --> C{Is there predictability or control?}
    C -- No --> Y[Relief weaker or mixed; cue may stay aversive]
    C -- Yes --> D{Is the context meaningful, safe, or rewarding?}
    D -- No --> Z[Main effect is relief only, often modest]
    D -- Yes --> E{Are expectations, learning, and individual traits supportive?}
    E -- No --> F[Some relief, limited pleasure]
    E -- Yes --> G[Highest chance of pain-offset pleasure or reward amplification]

    G --> H[Examples: relief after acute pain]
    G --> I[Examples: reward tastes better after pain]
    G --> J[Examples: consensual erotic or ritual pain]
    X --> K[Examples: chronic pain, trauma, nonconsensual pain]

The logic of the evidence is that pain increases pleasure through moderators, not by a simple linear law. citeturn29search2turn24search0turn24search1turn23search0turn14search0turn22search0

Methodological issues and gaps

A recurring methodological problem is conceptual conflation. Many studies actually measure relief, pain reduction, reward pursuit, or emotion regulation, then interpret the result as if pain itself had become pleasurable. Those are related but not identical constructs. Part of the literature’s confusion comes from switching too quickly between pain, relief, liking, wanting, and negative reinforcement. citeturn21search1turn10search4turn20search0

Another limitation is ecological mismatch. Most human experiments use cold pressor, brief shocks, capsaicin, or thermal pain. Those models are excellent for causal inference about acute pain and offset, but they do not mimic the uncertainty, disability, fatigue, and affective load of chronic pain. This is one reason chronic pain so often diverges from the “hurts so good” lab literature. citeturn23search0turn28search0turn22search0turn21search2

The chronic-pain neuroimaging field is also methodologically heterogeneous. A major meta-analysis found no robust, consistent group-level differences in brain responses to noxious stimuli across chronic-pain conditions, and highlighted underpowered studies, diverse pipelines, and false-positive risk. That cautions against overly strong claims about a single “chronic-pain brain” or a universal neural signature of pain–pleasure coupling. citeturn33search0

BDSM and sexual-context research remains especially limited. Sample sizes are usually modest, direct neurochemical measures are rare, and many studies are cross-sectional or rely on self-selected community samples. The best-supported claims are about threshold shifts, cortisol changes, and context-specific pain modulation—not definitive proof that endogenous opioids or dopamine are the main mechanisms in erotic pain. citeturn15search1turn14search0turn40search3

There is also a species-translation issue. Rodent and insect models are powerful for demonstrating reinforcement from pain relief, but they cannot directly report subjective pleasure. Conversely, humans can report pleasure, but invasive circuit-level manipulation is limited. The field still lacks tight bridges between subjective reports, neurochemistry, and causal circuit manipulation in the same paradigm. citeturn34search0turn34search3turn8search0turn30search0

Practical implications, actionable takeaways, and open questions

In clinical pain management, the evidence supports reducing unpredictability, helplessness, and meaningless persistence of pain rather than assuming suffering itself is therapeutic. Ethical use of expectation, verbal framing, ritual, and patient-clinician trust can enhance analgesia through placebo-related mechanisms without deception; at the same time, chronic pain patients should be assessed for anhedonia, depression, and reward-system dysregulation, not just nociceptive intensity. citeturn20search0turn24search0turn30search2turn22search0turn21search2

For therapy and psychiatry, one practical lesson is that some people use pain as a short-term emotion-regulation tool. That appears in laboratory self-injury studies and in broader “pain as emotion regulation” work. The implication is not that pain is helpful in the long run; it is that clinicians should explicitly assess whether relief learning, negative reinforcement, or sensory override is maintaining self-harm or compulsive relief-seeking. citeturn35search0turn35search4turn35search5

For sexual health, the data support a nonpathologizing but safety-focused approach. Consensual BDSM is not equivalent to sexual masochism disorder, and its pain-related effects are context-bound. Good practice therefore emphasizes consent, negotiation, injury prevention, aftercare, and clear differentiation between desired erotic pain and unwanted pain, coercion, or distressing impairment. citeturn15search1turn36search0

For opioid and analgesic ethics, pain relief is a genuine reward signal, especially in ongoing pain. That means analgesics can be reinforcing because they reduce aversive states, not only because they produce euphoria. Clinically, this argues for nuanced prescribing and for expanding non-opioid ways to produce relief, predictability, and restored reward engagement. citeturn8search0turn21search1turn22search0

The concise actionable takeaways are these:

Do not assume more pain yields more pleasure. That is only sometimes true for brief pain followed by salient relief. citeturn29search2turn28search0turn23search0
Treat chronic pain as a reward-disrupting condition, not a pleasure amplifier. citeturn22search0turn21search2
Use predictability, control, and supportive framing as analgesic levers. citeturn24search0turn20search0
In sexual or ritual settings, context is mechanistically central. Consent and meaning are part of the effect, not an afterthought. citeturn14search0turn15search1turn36search0
When people seek pain for relief, screen for maladaptive reinforcement loops. citeturn35search0turn35search4

Open research questions remain substantial. We still do not know how to integrate liking, wanting, control, prediction error, and bodily interoception into one model that spans acute pain, chronic pain, exercise, ritual, and sex. Direct neurochemical tests of BDSM contexts are sparse. Dose-response functions are poorly specified beyond simple lab paradigms. And the literature still needs stronger longitudinal and preregistered work to determine when pain-linked pleasure is adaptive, when it becomes compulsive, and how best to harness relief without valorizing suffering. citeturn15search1turn33search0turn21search2